0000950123-22-002169.txt : 20220211 0000950123-22-002169.hdr.sgml : 20220211 20220211164117 ACCESSION NUMBER: 0000950123-22-002169 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 EFFECTIVENESS DATE: 20220211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ponoi Management, LLC CENTRAL INDEX KEY: 0001720702 IRS NUMBER: 821659880 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19916 FILM NUMBER: 22621893 BUSINESS ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 4158652050 MAIL ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001720702 XXXXXXXX 12-31-2021 12-31-2021 false Ponoi Management, LLC

1 Letterman Drive Building D, Suite M-900 San Francisco CA 94129

13F HOLDINGS REPORT 028-19916 Y Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412) James Evangelista (415) 865-2050 /s/ James Evangelista San Francisco CA 02-11-2022 0 4 108463 false INFORMATION TABLE 2 9960.xml INFORMATION TABLE FOR FORM 13F Revolution Medicines Inc COM 76155X100 17242 685011 SH SOLE 685011 0 0 RAPT Therapeutics Inc COM 75382E109 58747 1599417 SH SOLE 1599417 0 0 NGM Biopharmaceuticals Inc COM 62921N105 23004 1298908 SH SOLE 1298908 0 0 Nurix Therapeutics Inc COM 67080M103 9470 327122 SH SOLE 327122 0 0